Q&A: Brent Saunders on pushing Bausch out of neutral, scrutinizing new hires and why TrumpRx matters
Brent speaks with Senior Biopharma Correspondent Andrew Dunn for an Endpoints News feature.
Bausch + Lomb CEO Brent Saunders on growth outlook: Biggest contributor will be in surgical
Brent joins CNBC’s “Squawk Box” live in studio.
Bausch + Lomb CEO Brent Saunders on Comeback, R&D Innovation, and Eye Care’s Evolution
Brent joins the New York Stock Exchange’s “Inside the ICE House” podcast for a wide-ranging interview in advance of Bausch + Lomb Investor Day.
“CHABÁN Podcast” interview
Brent joins Alejandro Chabán for a discussion on reinvention, growth and leadership.
“Opening Bid” podcast interview
Brent joins Brian Sozzi on the Yahoo Finance “Opening Bid” podcast for a wide-ranging conversation.
Bausch + Lomb CEO: Right on track with our important initiatives
Brent joins CNBC’s “Money Movers” from the J.P. Morgan Healthcare Conference to discuss how the company has evolved in his two years as CEO and transforming the standard of care in eye health.